JO
Jay Olson Oppenheimer Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
BCYC
1
Bicycle Therapeutics
BCYC
$483M
| $6.97 | $44 |
531%
upside
| Outperform | 25 days ago |
|
2
MindMed
MNMD
$702M
| $9.23 | $25 |
171%
upside
| Outperform | 1 month ago |
|
3
ATAI Life Sciences
ATAI
$977M
| $4.56 | $14 |
207%
upside
| Outperform | 1 month ago |
|
4
Praxis Precision Medicines
PRAX
$970M
| $46.09 | $115 |
150%
upside
| Outperform | 1 month ago |
|
5
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $22 |
14%
downside
| Perform | 2 months ago |
|
|
TVRD
6
Tvardi Therapeutics, Inc. Common Stock
TVRD
$285M
| $30.44 | $65 |
114%
upside
| Outperform | 3 months ago |
|
7
Revolution Medicines
RVMD
$7.28B
| $38.95 | $75 |
93%
upside
| Outperform | 3 months ago |
|
8
Nektar Therapeutics
NKTR
$684M
| $35.98 | $90 |
150%
upside
| Outperform | 5 months ago |
|
9
Denali Therapeutics
DNLI
$2.16B
| $14.79 | $42 |
184%
upside
| Outperform | 6 months ago |
|
10
Exelixis
EXEL
$10.1B
| $37.38 | $33 |
12%
downside
| Perform | 7 months ago |
|
11
Intellia Therapeutics
NTLA
$1.25B
| $11.62 | $40 |
244%
upside
| Outperform | 7 months ago |
|
12
Terns Pharmaceuticals
TERN
$618M
| $7.06 | $20 |
183%
upside
| Outperform | 9 months ago |
|
13
Biogen
BIIB
$20.5B
| $139.94 | $255 |
82%
upside
| Outperform | 10 months ago |
|
14
Incyte
INCY
$16.7B
| $85.44 | $82 |
4%
downside
| Outperform | 10 months ago |
|
15
Madrigal Pharmaceuticals
MDGL
$9.61B
| $431.21 | $350 |
19%
downside
| Outperform | 10 months ago |
|
16
Viking Therapeutics
VKTX
$2.98B
| $26.53 | $138 |
420%
upside
| Outperform | 11 months ago |
|
17
Amgen
AMGN
$151B
| $280.10 | $380 |
36%
upside
| Outperform | 1 year ago |
|
18
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $219 |
56%
upside
| Outperform | 1 year ago |
|
19
CRISPR Therapeutics
CRSP
$4.8B
| $52.74 | $95 |
80%
upside
| Outperform | 1 year ago |
|
20
Ionis Pharmaceuticals
IONS
$9.46B
| $59.35 | $75 |
26%
upside
| Outperform | 1 year ago |
|